Updates

September 08, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub: Press Release regarding exclusive Licence Agreement with Vellore Institute of Technology (‘VIT’), Vellore for Vitamin B12 Fortification Technology. We are pleased to inform that the Company has entered into an exclusive Licence Agreement with VIT for Vitamin B12 Fortification Technology. Press Release issued by the Company in this regard is enclosed herewith for your information purpose. This is a general update by the Company and does not constitute an event or information falling within the scope of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you, Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head - Legal Membership No. A33861 Encl: As above Fermenta Biotech Signs Exclusive Licence Agreement with VIT Vellore for Vitamin B12 Fortification Technology NSE FERMENTA | BSE 506414 | Bloomberg FERMENTA:IN | Reuters FERM.BO • Exclusive licence agreement covers VIT Vellore’s technology for natural in-situ Vitamin B12 fortification in fermented foods • Technology enables Vitamin B12 enrichment during the natural fermentation process across commonly consumed food like curd, idli/dosa batters, appam, breads and other traditional fermented foods • Collaboration combines VIT’s research capabilities with Fermenta’s expertise in vitamins, nutritional premixes and food fortification Mumbai, 8 September 2026: Fermenta Biotech Limited, India's leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for the global markets, today announced the signing of an Exclusive Licence Agreement with Vellore Institute of Technology (“VIT”), Vellore, for the commercialisation of a technology for Natural In-Situ Vitamin B12 Fortification in Fermented Foods. Vitamin B12 deficiency remains a significant nutritional challenge, particularly among vegetarian and vegan populations with limited natural dietary sources. Fortifying widely consumed foods offers a potentially more accessible approach to improving intake than relying solely on tablets or injectables. The demand for Vitamin B12 solutions is also being supported by trends such as vegetarianism, ageing populations and greater focus on fortified foods. Against this backdrop, VIT’s technology, covered under Indian Patent Application No. 202441015300, has been developed by Dr. Krishnan Venkataraman and his team at the Centre for BioSeparation Technology (“CBST”), VIT Vellore. It provides an approach to enhancing Vitamin B12 directly within fermented foods during the natural fermentation process, rather than through the conventional addition of Vitamin B12 to the finished food product. The process uses selected nutrients and cofactors during fermentation to enhance the formation of Vitamin B12 within the food matrix. It is designed to integrate with existing food fermentation processes without requiring substantial alterations to conventional production methods. Laboratory studies demonstrated approximately 80% retention of the enhanced Vitamin B12 levels following cooking, indicating the technology’s potential applicability across both fermented and subsequently cooked foods. Commenting on the milestone, Mr. Prashant Nagre, Managing Director, Fermenta Biotech Limited, said: “Fermenta’s collaboration with VIT Vellore brings together scientific depth and industrial capability with a shared purpose: to make nutrition more meaningful, relevant and accessible. This technology opens a differentiated route to Vitamin B12 enrichment and extends Fermenta’s food fortification capabilities beyond customised vitamin and mineral premixes. It also reflects a larger ambition of translating emerging nutrition research into scalable solutions that can become part of everyday foods and, over time, contribute to better nutritional outcomes. Our focus will now be on advancing this technology towards practical, market-ready applications with the potential to support improved nutritional outcomes.”. Commenting on the milestone during the signing and exchange of the exclusive licence agreement, G . Viswanathan, Chancellor VIT, said: “This MoU with Fermenta Biotech Ltd is a significant one and it reflects VIT’s long-standing commitment to transform academic learning into a solution provider for real world challenges especially in healthcare industry. I am confident that this MoU will contribute to India’s capabilities in nutritional science and also fight against micronutrient deficiency.” The next phase will include application development, nutritional validation, assessment of final Vitamin B12 concentrations, regulatory evaluation and development of commercially viable solutions for relevant food applications. The commercial potential extends across FMCG, food and nutrition, nutraceutical and broader health-related applications. Fermenta will leverage its capabilities in this domain to enable scale-up into accessible pre-mixes and fortified food solutions, exemplifying a meaningful industry-academia synergy to combat widespread dietary deficiencies worldwide. About Fermenta Fermenta Biotech Limited (www.fermentabiotech.com) delivers best-in-class, science-validated nutritional ingredients across pharmaceuticals, dietary supplements, food & beverage, veterinary, and animal nutrition industries. Our state- of-the-art manufacturing facilities located at Kullu (Himachal Pradesh), Dahej (Gujarat), and Tirupati (Andhra Pradesh), supported by the R&D Excellence Centre at Thane (near Mumbai) drive Fermenta's comprehensive portfolio of premium vitamins, nutritional premixes and ingredients that exceed the unique needs and stringent regulatory standards of over 400 discerning customers in more than 60 countries. With decades of expertise at global-scale complex manufacturing, Fermenta also provides research-based custom solutions in green chemistry, APIs & intermediates, and environmental solutions. About VIT, Vellore Founded in 1984 as Vellore Engineering College, it attained University status in the year 2001. VIT is one of the prominent private deemed university in India where over 40000 students study various programmes at the Vellore campus. It is ranked 16th in Engineering category and 14th in Universities category as per the NIRF rankings 2025. Safe Harbour Statement Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, market opportunities, competitive positioning, slump sale transaction potential, the progress and results of research and development, potential project characteristics, project potential, and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements due to various factors including market conditions, regulatory changes, competitive dynamics, and other business risks. Fermenta Biotech Limited assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors, except as and when required by applicable law. Contact Varadvinayak Khambete| varadvinayak.khambete@fermentabiotech.com